CTYPE html> ProCanBio | Biomarker Card

Biomarker Card

This biomarker card gives comprehensive information about each biomarker.
Detailed Information
Biomarker ID1177
PMID23891454
Year2013
BiomarkerGenetic Risk score based on 41 SNPs (rs10187424, rs721048, rs1465618, rs13385191, rs12621278, rs2292884, rs4857841, rs6763931, rs10936632, rs17021918, rs12500426, rs7679673, rs2121875, rs12653946, rs130067, rs1983891, rs339331, rs9364554, rs10486567, rs6465657, rs1512268, rs1447295, rs6983561, rs16901979, rs10086908, rs12543663, rs620861, rs6983267, rs16902094, rs1016343, rs13252298, rs445114, rs10993994, rs4962416, rs10896449, rs11228565, rs12418451, rs10875943, rs9600079, rs4430796, rs11649743, rs1859962, rs8102476, rs17632542, rs2735839, rs9623117, rs5759167, rs5945619, rs5919432)
Biomarker BasisMutation Based
BiomoleculeMutation
SourceBlood
SubjectsHumans
RegulationIncreased Score with Increased risk of Prostate Cancer
Odds Ratio/Hazard Ratio/Relative RiskUnivariate: [OR: 1.67 (95% CI: 1.11- 2.50); Multivariate: [OR: 1.60 (95% CI: 1.05-2.45)]
Effect on PathwaysNA
ExperimentProstate Cancer Vs no Prostate Cancer
Type of BiomarkerDiagnostic
Cohort172 men from STHLM cohort underwent this study out of which 47 had prostate cancer
SenstivityNA
SpecificityNA
AUCNA
AccuracyNA
Level Of SignificanceUnivariate: p=0.014; Multivariate: 0.029
Method Usedmatrix- assisted laser desorption/ionization time-of-flight mass spectrometry
ClinicalNo
RemarksNA
Clinical Trial NumberNA
Degree Of ValidityNot validated on independent patient dataset
Technical NameNA